Genome sequencing, assembly and annotation of ten bacteriophages infecting Pseudomonas aeruginosa.
Developing new treatment options against carbapenem-resistant P. aeruginosa is a clinical priority in the respiratory field due to the limited availability of effective treatments. Phage therapy represents a novel, personalized approach to treating multidrug resistant infections, particularly in clinical scenarios involving carbapenem-resistant P. aeruginosa. This study aimed to identify new potential therapeutic bacteriophages to control P. aeruginosa in ventilator-associated pneumonia (VAP) context. This submission includes the complete genome sequences of ten bacteriophages infecting Pseudomonas aeruginosa, isolated as part of a phage characterization study. The isolates are designated Pseudomonas Phage BCN_1; Pseudomonas Phage BCN_21; Pseudomonas Phage BCN_23; Pseudomonas Phage BCN_24; Pseudomonas Phage BCN_26; Pseudomonas Phage BCN_27; Pseudomonas Phage BCN_28; Pseudomonas Phage BCN_30; Pseudomonas Phage BCN_31, and Pseudomonas Phage BCN_32.